COYA

Coya Therapeutics, Inc. - Common Stock (COYA)

About Coya Therapeutics, Inc. - Common Stock (COYA)

Coya Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing proprietary new therapies to enhance the function of regulatory T cells. Its pipeline includes Treg Modifying Biologics, Allogeneic Treg-Derived Exosomes, and Autologous Treg Cell Therapy. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.

Details

Daily high

$5.04

Daily low

$4.83

Price at open

$4.94

52 Week High

$7.75

52 Week Low

$3.71

Market cap

114.7M

Dividend yield

Volume

100,047

Avg. volume

133,893

P/E ratio

-4.89

Coya Therapeutics, Inc. - Common Stock News